Theranostic barcoded nanoparticles for personalized cancer medicine
Determining the most effective treatment for each cancer patient is a key challenge in cancer therapy. In this article, the authors show, in a mouse model of breast cancer, that DNA barcoded nanoparticles can be used for pre-screening the efficacy of anticancer drugs.
Guardado en:
Autores principales: | Zvi Yaari, Dana da Silva, Assaf Zinger, Evgeniya Goldman, Ashima Kajal, Rafi Tshuva, Efrat Barak, Nitsan Dahan, Dov Hershkovitz, Mor Goldfeder, Janna Shainsky Roitman, Avi Schroeder |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/180b7ed375a34db78cbeed4472757033 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polyrotaxane-based supramolecular theranostics
por: Guocan Yu, et al.
Publicado: (2018) -
Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019) -
Theranostic applications of nanoparticles in neurodegenerative disorders
por: Ramanathan S, et al.
Publicado: (2018) -
In vivo imaging and tracking of exosomes for theranostics
por: Ning Ma, et al.
Publicado: (2021) -
DNA barcoding in the cycadales: testing the potential of proposed barcoding markers for species identification of cycads.
por: Chodon Sass, et al.
Publicado: (2007)